Philadelphia, PA, United States of America

Jason Coleman

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jason Coleman in Pharmaceutical Formulations

Introduction

Jason Coleman, located in Philadelphia, PA, is an accomplished inventor known for his significant contributions to pharmaceutical sciences. He holds one patent that showcases his innovative approach to drug formulation, specifically focusing on abiraterone acetate.

Latest Patents

Jason Coleman's notable patent is for the "Abiraterone Acetate Formulation and Methods of Use." This patent details pharmaceutical compositions, including unit dosage forms that comprise abiraterone acetate. Furthermore, it outlines methods for producing and utilizing such compositions, providing valuable insights into enhancing the efficacy of pharmaceutical treatments.

Career Highlights

Currently, Jason is associated with Iceutica Inc., a company recognized for its commitment to developing innovative pharmaceutical solutions. His work contributes to advancing the field of oncology through improved drug formulations. With one patent to his name, he demonstrates his potential in shaping the future of medicine.

Collaborations

In his professional journey, Jason has collaborated with notable colleagues such as Maura Murphy and Paul Nemeth. Together, they share a vision of creating impactful pharmaceutical advancements that can improve patient outcomes and enhance therapeutic options.

Conclusion

Jason Coleman's inventive spirit and dedication to pharmaceutical innovation reflect his significant role in advancing medical science. His contributions, particularly through his patent on abiraterone acetate formulations, illustrate the importance of research and collaboration in developing effective therapies for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…